Jan. 23, 2013
/PRNewswire/ -- Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceuticals and industrial enzyme industries, announced today that it has been upgraded by OTC Markets to "
" which is the highest trading tier on the OTC Pink marketplace. The disclosures required for this upgrade have been posted on the OTC Markets website (
) under Dyadic's ticker symbol, "DYAI."
Dyadic's President and CEO,
, stated, "Completion of the upgrade to OTC Pink Current Information is one of several positive steps Dyadic has taken to strengthen our stockholder base and build stockholder value by providing greater transparency through periodic press releases and quarterly and annual disclosures, financial statements and investor conference calls. The confidence and protections provided by these additional disclosures contribute to the significantly greater liquidity of the OTC Pink Current Information Tier as compared to the prior tier assigned to Dyadic."
The Current Information Tier applies to reporting companies that submit filings to regulators with powers of review and that make the filings publicly available and non-reporting companies that make current information publicly available on the OTC Disclosure and News Service pursuant to OTC Markets Guidelines for Providing Adequate Current Information. Disclosures are published pursuant to paragraphs (a)(5)(i) to (xiv), inclusive, and paragraph (a)(5)(xvi) of Rule 240.15c2-11 and the OTC Disclosure Guidelines.
Dyadic International, Inc. is a global biotechnology company that uses its patented and proprietary technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceuticals and industrial enzyme industries.